RecruitingNot ApplicableNCT06512974

NeuroTrainer Cognitive Training For Academic Focus

A Feasibility and Efficacy Study of NeuroTrainer Cognitive Training in Students With and Without Attention-Related Difficulties

Sponsor

NeuroTrainer

Enrollment

155 participants

Start Date

Sep 1, 2024

Study Type

INTERVENTIONAL

Conditions

ADHD - Combined Type ADHD Predominantly Inattentive Type ADHD, Predominantly Hyperactive - Impulsive

Summary

This clinical trial aims to evaluate the feasibility and efficacy of NeuroTrainer cognitive training in improving attentional and executive control functions in students with and without attention-related difficulties.

Eligibility

Min Age: 11 YearsMax Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called NeuroTrainer for people with adhd - combined type, adhd predominantly inattentive type, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 11 Years to 17 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.